J.-L. Lee

机构：Ulsan College, Asan Medical Center, University of Ulsan

发表论文 19 篇 · 总被引 524 次 · h-index 9

代表论文

• EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma (2023 · Annals of Oncology · 被引 170)
• Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma (2012 · Annals of Oncology · 被引 101)
• The Efficacy and Safety of Sunitinib in Korean Patients with Advanced Renal Cell Carcinoma: High Incidence of Toxicity Leads to Frequent Dose Reduction (2010 · Japanese Journal of Clinical Oncology · 被引 86)
• Docetaxel Monotherapy as a Second-line Treatment after Failure of Fluoropyrimidine and Platinum in Advanced Gastric Cancer: Experience of 154 Patients with Prognostic Factor Analysis (2007 · Japanese Journal of Clinical Oncology · 被引 42)
• A Case of Bone Marrow Necrosis with Thrombotic Thrombocytopenic Purpura as a Manifestation of Occult Colon Cancer (2004 · Japanese Journal of Clinical Oncology · 被引 37)
• First-line pembrolizumab (pembro) monotherapy for advanced non-clear cell renal cell carcinoma (nccRCC): Updated follow-up for KEYNOTE-427 cohort B (2019 · Annals of Oncology · 被引 18)